Back to search
Doxorubicin Induced Cardiomyopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Doxorubicin Induced Cardiomyopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Doxorubicin Induced Cardiomyopathy trials you may qualify forThis study aims to evaluate the efficacy and safety of telmisartan as a cardioprotective agent in patients receiving doxorubicin-based chemotherapy, with the go…
Investigators will evaluate the safety, tolerability, and feasibility of a risk-guided cardioprotective treatment strategy with carvedilol, as compared to usual…
Anthracyclines treat up to 60% of childhood malignancies with remarkable improvements survival rates. Unfortunately anthracyclines are associated with an increa…